Search clinical trials for: hormone receptor positive early breast cancer
Total 155079 results
-
Dana-Farber Cancer InstitutePfizerCompletedHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone Receptor (HR)-Positive Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedTriple Negative Breast Cancer | Endometrial Cancer | Hormone Receptor Positive, HER2 Negative Breast CancerUnited States
-
Stemline Therapeutics, Inc.CompletedHormone Receptor Positive Malignant Neoplasm of BreastUnited States
-
Velindre NHS TrustAstraZeneca; Cardiff and Vale University Health Board; Covance; Cenduit LLCActive, not recruitingEstrogen Receptor Positive Breast CancerUnited Kingdom
-
Dana-Farber Cancer InstituteNovartisCompleted
-
PfizerCompletedBreast CancerAustralia, India
-
Celcuity, Inc.Completed
-
Novartis PharmaceuticalsGlaxoSmithKlineCompletedNeoplasms, BreastBelgium, United Kingdom, Croatia, Hungary, Argentina, Australia, Germany, Israel, Japan, Poland, Russian Federation, Spain, France, Korea, Republic of, Hong Kong, United States, Brazil, Bulgaria, China, India, Ireland, Italy, Philip... and more
-
Syndax PharmaceuticalsCompleted
-
Hoffmann-La RocheTerminatedEstrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast CancerCanada, United States, United Kingdom, Australia, Germany
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditions
-
H. Lee Moffitt Cancer Center and Research InstituteAstraZenecaTerminatedBreast Cancer | Hormone Receptor Positive TumorUnited States
-
Syndax PharmaceuticalsCompletedBreast Cancer | ER+ Breast Cancer | Estrogen Receptor-Positive Breast Cancer | Breast Cancer, Estrogen Receptor-PositiveUnited States, Czechia, Canada, Hungary, Russian Federation
-
NSABP Foundation IncPfizer; Genomic Health®, Inc.CompletedBreast CancerUnited States, Canada
-
Silverback TherapeuticsWithdrawnSquamous Cell Carcinoma of Head and Neck | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Urothelial Carcinoma | Hormone Receptor-positive/HER2-negative Breast Cancer
-
Emory UniversityNovartisTerminatedStage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
Dana-Farber Cancer InstituteNovartisTerminatedMetastatic Hormone-Receptor-Positive (HR+) Breast Cancer | HER2-Negative Breast Cancer | Metastatic Epithelial Ovarian CancerUnited States
-
Sun Yat-sen UniversityCompletedBreast Cancer MetastaticChina
-
PfizerCompletedBreast NeoplasmsSpain, Korea, Republic of, United States, Australia, Italy, Russian Federation
-
University of California, San FranciscoDana-Farber Cancer Institute; Translational Breast Cancer Research ConsortiumCompletedMetastatic Breast Cancer | Hormone Receptor PositiveUnited States
-
M.D. Anderson Cancer CenterCompletedAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Breast CarcinomaUnited States
-
University of Colorado, DenverCompletedBreast Cancer | Stage II Breast Cancer | Stage III Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedMetastatic or Locally-advanced Unresectable Breast CancerUnited States
-
German Breast GroupNovartisCompletedBreast Cancer | Hormone Receptor Positive TumorGermany
-
Boehringer IngelheimCompletedNeoplasmsSpain, Korea, Republic of, Belgium, Taiwan, United Kingdom, Austria, France, Netherlands, Ireland, Sweden
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompletedBreast Cancer | Breast Cancer - Female | Breast Cancer - MaleUnited States
-
NSABP Foundation IncRoyal Marsden NHS Foundation Trust; Pfizer; Institute of Cancer Research, United...CompletedBreast Cancer | Breast Tumors | Breast CarcinomaUnited Kingdom, United States, Canada
-
Palleos Healthcare GmbHPfizer; Cankado GmbH; WSG WOMEN´S HEALTHCARE STUDY GROUP; AGO-TraFo; AGO-B; Deutsche...Terminated
-
Yonsei UniversityCompletedMetastatic Breast CancerKorea, Republic of
-
Syndax PharmaceuticalsCompletedBreast Cancer | Estrogen Receptor Positive Breast CancerUnited States
-
Novartis PharmaceuticalsNo longer availableAdvanced Hormone Receptor Positive (HR+) Breast Cancer
-
University of VirginiaWithdrawnBreast Cancer | Estrogen Receptor-positive Breast CancerUnited States
-
British Columbia Cancer AgencyTerminated
-
PfizerTerminated
-
Washington University School of MedicineWithdrawn
-
Emory UniversityNational Cancer Institute (NCI)WithdrawnPrognostic Stage IV Breast Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Brain | Metastatic Breast Carcinoma | Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingHER2/Neu Negative | Estrogen Receptor-positive Breast Cancer | Stage IV Breast Cancer AJCC v6 and v7United States
-
Novartis PharmaceuticalsCompletedAdvanced Metastatic Breast CancerGermany
-
Immutep S.A.S.CompletedAdenocarcinoma Breast Stage IVNetherlands, United Kingdom, France, Belgium, Germany, Hungary, Poland
-
Georgetown UniversityUniversity of Chicago; Thomas Jefferson UniversityCompletedHormone Receptor Positive HER-2 Negative Breast CancerUnited States
-
Renske AltenaTerminatedHER2-positive Breast Cancer | Early-stage Breast CancerSweden
-
The Methodist Hospital Research InstituteMillennium Pharmaceuticals, Inc.CompletedEstrogen Receptor Positive Breast CancerUnited States
-
Novartis PharmaceuticalsBreast International Group; SOLTI Breast Cancer Research GroupCompletedNeoplasms, BreastFrance, Spain, United Kingdom, Belgium, Argentina, Czechia, Germany, Italy, Norway, Russian Federation, Sweden, Taiwan, Hong Kong, Brazil, Hungary, India, Korea, Republic of, Pakistan, Peru, Romania, South Africa, Ukraine, Canada, Lit...
-
Robert Bosch Gesellschaft für Medizinische Forschung...Completed
-
Hoffmann-La RocheCompletedBreast CancerUnited States, Canada, Denmark, France, Italy, Poland, Portugal, Spain, United Kingdom, Norway, Germany, Mexico
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma | Solid CancersUnited States, Spain, France, Canada
-
Eli Lilly and CompanyTerminatedMetastatic Breast CancerUnited States, Puerto Rico
-
Mothaffar RimawiTerminated
-
Odonate Therapeutics, Inc.TerminatedBreast CancerKorea, Republic of, United States, Spain, Canada, Singapore, Taiwan, Australia, Belgium, Thailand, Hungary, Germany, United Kingdom, France, Ukraine, Austria, Czechia, Italy, Poland, Russian Federation
-
Odonate Therapeutics, Inc.TerminatedBreast CancerUnited States, Spain, Korea, Republic of, Taiwan, Australia, Canada